Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Orvepitant 10mg	79
Overall Study	STARTED	Orvepitant 20mg	78
Overall Study	STARTED	Orvepitant 30mg	79
Overall Study	STARTED	Placebo	79
Overall Study	COMPLETED	Orvepitant 10mg	69
Overall Study	COMPLETED	Orvepitant 20mg	74
Overall Study	COMPLETED	Orvepitant 30mg	69
Overall Study	COMPLETED	Placebo	75
Overall Study	NOT COMPLETED	Orvepitant 10mg	10
Overall Study	NOT COMPLETED	Orvepitant 20mg	4
Overall Study	NOT COMPLETED	Orvepitant 30mg	10
Overall Study	NOT COMPLETED	Placebo	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02993822/flow